What question did this study set out to answer?

The aim is to explore the role of TRIM69 in systemic lupus erythematosus (SLE) and its potential as a predictive bioindicator.

March 1, 2026

Increased expression of TRIM69 in peripheral blood from systemic lupus erythematosus and its clinical significance

Key Points

The aim is to explore the role of TRIM69 in systemic lupus erythematosus (SLE) and its potential as a predictive bioindicator.
Analyzed TRIM69 expression in peripheral blood samples from individuals with systemic lupus erythematosus.
Developed a predictive model incorporating serum TRIM69 levels, hemoglobin (HGB), and neutrophil to lymphocyte ratio (NLR).
Found elevated TRIM69 levels in the blood of individuals with SLE.
Demonstrated the potential of using TRIM69, HGB, and NLR as bioindicators for disease forecast and progression.

Abstract

The study suggested that the elevated TRIM69 may play a role in SLE pathogenesis and predictive model based on serum TRIM69 levels, HGB, and NLR act as bioindicator for forecast and progression of diseases.

Bookmark

Cite This Study

Zhan et al. (Mon,) studied this question.

synapsesocial.com/papers/69a3d6eaec16d51705d2da5b https://doi.org/https://doi.org/10.55563/clinexprheumatol/3pk20x

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark